Optimisation of Protein Extraction from Medicinal Cannabis Mature Buds for Bottom-Up Proteomics

• Published in: Molecules (Basel, Switzerland) Vol. 24; no. 4; p. 659
• Main Authors: Vincent, Delphine, Rochfort, Simone, Spangenberg, German
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 13-02-2019; MDPI
• Subjects: apical bud; Cannabidiol; Funding; Genomes; guanidine-HCl; Medical marijuana; Milk; nLC-MS/MS; Peptides; Proteins; Proteomics; trichome; trypsin digestion; urea; trichome; guanidine-HCl; trypsin digestion; apical bud; nLC-MS/MS; urea
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules24040659

Medicinal cannabis is used to relieve the symptoms of certain medical conditions, such as epilepsy. Cannabis is a controlled substance and until recently was illegal in many jurisdictions. Consequently, the study of this plant has been restricted. Proteomics studies on
reported so far have been primarily based on plant organs and tissues other than buds, such as roots, hypocotyl, leaves, hempseeds and flour. As far as we know, no optimisation of protein extraction from cannabis reproductive tissues has been attempted. Therefore, we set out to assess different protein extraction methods followed by mass spectrometry-based proteomics to recover, separate and identify the proteins of the reproductive organs of medicinal cannabis, apical buds and isolated trichomes. Database search following shotgun proteomics was limited to protein sequences from
and closely related species available from UniprotKB. Our results demonstrate that a buffer containing the chaotrope reagent guanidine hydrochloride recovers many more proteins than a urea-based buffer. In combination with a precipitation with trichloroacetic acid, such buffer proved optimum to identify proteins using a trypsin digestion followed by nano-liquid chromatography tandem mass spectrometry (nLC-MS/MS) analyses. This is validated by focusing on enzymes involved in the phytocannabinoid pathway.